Highlands Oncology Group Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Highlands Oncology Group's estimated annual revenue is currently $110.4M per year.(i)
  • Highlands Oncology Group's estimated revenue per employee is $337,500

Employee Data

  • Highlands Oncology Group has 327 Employees.(i)
  • Highlands Oncology Group grew their employee count by 8% last year.

Highlands Oncology Group's People

NameTitleEmail/Phone
1
COO at Highlands Oncology GroupReveal Email/Phone
2
CEOReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
Chief Operating OfficerReveal Email/Phone
5
Director Surgical OncologyReveal Email/Phone
6
Assistant Director EngineeringReveal Email/Phone
7
Director Medical Physics and ResearchReveal Email/Phone
8
Director Marketing & Administratice SvcsReveal Email/Phone
9
Chief Clinical OfficerReveal Email/Phone
10
Director, Multidisciplinary Programs, Lung Cancer Screening & New Patient IntakeReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$36.5M1350%N/AN/A
#2
$18M7410%N/AN/A
#3
$54.6M1847%N/AN/A
#4
$8.6M408%N/AN/A
#5
$45.7M154N/AN/AN/A
#6
$145.5M4315%N/AN/A
#7
$28.9M1070%N/AN/A
#8
$10.8M500%N/AN/A
#9
$13.1M5410%N/AN/A
#10
$36.5M1356%N/AN/A
Add Company

What Is Highlands Oncology Group?

Highlands Oncology Group offers comprehensive cancer care. From chemotherapy to massage therapy, we are here to compassionately serve you and your family. Bringing Hope and Healing to those in Northwest Arkansas.

keywords:N/A

N/A

Total Funding

327

Number of Employees

$110.4M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Highlands Oncology Group News

2022-03-22 - Northwest Arkansas' Most Expensive Home Sales of 2021

... principal broker of Limbird Real Estate Group in Bentonville. ... is an oncologist and a founding member of Highlands Oncology Group.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$73.4M356N/AN/A
#2
$67.1M3587%N/A
#3
$130.9M3613%N/A
#4
$68.4M3656%N/A
#5
$101.2M3687%N/A